Do bevacizumab solutions interact with silicone or polyurethane catheters during an infusion through implantable venous access ports?
| Autor: | Nicolas Tokhadzé, Régis Cueff, Philip Chennell, Valérie Sautou |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Catheterization
Central Venous Materials science Bevacizumab Scanning electron microscope Polyurethanes Silicones Biomedical Engineering Biophysics Bioengineering 02 engineering and technology 030226 pharmacology & pharmacy Biochemistry Biomaterials Contact angle 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Silicone Life Sciences–Chemistry interface medicine Humans Shore durometer Polyurethane 021001 nanoscience & nanotechnology 3. Good health Venous access Catheter chemistry 0210 nano-technology Biotechnology medicine.drug Biomedical engineering |
| Zdroj: | J R Soc Interface |
| ISSN: | 1742-5662 1742-5689 |
| DOI: | 10.1098/rsif.2018.0721 |
| Popis: | This work aims to evaluate the possible impact of interactions between bevacizumab solutions and an implantable port equipped with a silicone or a polyurethane catheter after infusion through a complete infusion set-up in simulated use conditions. Physico-chemical and structural stability of bevacizumab solution was assessed by visual examination, subvisible particles counting, dynamic light scattering, size exclusion chromatography and ion exchange chromatography. Mechanical properties of the catheters were evaluated by measuring Shore A hardness, strain at break, strain at stress and Young's modulus. The physico-chemical surface state of the catheters was assessed by FTIR-ATR spectroscopy, scanning electron microscopy (SEM) and by water contact angle measurement. The analysis of the bevacizumab solution did not highlight any signs of instability or loss of active substance. Mechanical properties of both materials remained unchanged after the infusion. During material analysis, a decrease in water contact angle observed after infusion and was more pronounced for polyurethane catheters than for silicone, possibly due to bevacizumab adsorption or possible leachable extraction from the materials. Surface modifications were also noted at SEM. This study did not highlight any modifications that could alter the quality of the bevacizumab infusion, nor of the infusion catheter in polyurethane or silicone, despite a modification of surface hydrophilicity. Even if after a single infusion, implantable ports remained safe to use, they aim to be used for several infusion of various drugs during their lifetime, and further studies are needed to assess the impact of repeated infusions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|